GlassScriptPhysician profile
Michael Aaron Markovitz
NPI 1376004028
$3,252.93
in general payments reported to CMS, 2019-2025
9 companies · $1,741 in 2025
The $1,741 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $80.86 · 2023: $336 · 2024: $1,096 · 2025: $1,741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,836.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $748.90 | 2025 | Indigo System, Ruby Coil, Penumbra System |
| Boston Scientific Corporation | $735.72 | 2024-2025 | Accolade Sr, Embold Fibered, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) |
| Inari Medical, INC. | $514.38 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bard Peripheral Vascular, INC. | $254.12 | 2025 | Powerport M.R.I. Implantable Port, Fluency Endovascular Stent Graft |
| Stryker Corporation | $187.21 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Clottriever Bold Catheter |
| Angiodynamics, INC. | $160.02 | 2024 | Alphavac, Micro Access, Angiodynamics |
| Trisalus Life Sciences, INC. | $155.51 | 2024 | Trinav Infusion System |
| Okami Medical, INC. | $43.04 | 2025 | Lobo |
| Medtronic, INC. | $37.35 | 2024-2025 | Mvp, Abre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Markovitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.